Ms Bargmann has been Chief Executive Officer of Proteo Biotech AG since November 2005, and Chairman of the Management Board of Proteo Biotech AG since December 2014. Between 2000 and 2005 she served as a Member of the Supervisory Board of the company.
She has been President, Chief Executive Officer and Chief Financial Officer of Proteo Inc. from November 2005 to November 2018, and a Member of the Board of Directors of Proteo Inc. since the inception of the company in 2000 to 2018.
Ms Bargmann has 18 years of research experience in her previous position as head of the laboratory for enzyme research in the department of dermatology at the University of Kiel.
Dr. Paal has been a Member of the Management Board of Proteo Biotech AG since December 2014.
He has more than 13 years of experience in the health care industry.
Previously, he served as Director Business Development Therapeutic Apheresis at Fresenius Medical Care.
Dr. Paal holds a Dr. rer. nat. in Biology and an M.Sc. in Pharmaceutical Medicine.
Chair of the Dept. of Applied Cell Therapy, University of Kiel
Director of the clinical research group ”Mechanisms of cutanious inflammatory reactions“, University of Kiel